Peter Wildgoose

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

C. Michael Gibson, Roxana Mehran, Christoph Bode et al. · New England Journal of Medicine · 2016 · 1.5K citations · Full text

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

Alok A. Khorana, Gerald A. Soff, Ajay K. Kakkar et al. · New England Journal of Medicine · 2019 · 683 citations · Full text

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

George Dangas, Jan G.P. Tijssen, Jochen Wöhrle et al. · New England Journal of Medicine · 2019 · 526 citations · Full text

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation

Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein et al. · European Heart Journal · 2014 · 365 citations

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

C. Michael Gibson, Roxana Mehran, Christoph Bode et al. · American Heart Journal · 2014 · 167 citations

Percutaneous Coronary Intervention, Thrombosis, Pioneer Af-pci +12